FDA rejects Gilead's cystic fibrosis drug
The US Food and Drug Administration has rejected Gilead Science’s inhaled cystic fibrosis drug aztreonam lysine on the grounds an additional clinical study is required. - News - PharmaTimes
by Katrina Megget
https://www.pharmatimes.com/news/fda_rejects_gileads_cystic_fibrosis_drug_987840